August 1, 20190Comments

July 2019 Stock Picking Accolades: #2 in Healthcare, #5 in Industrials and #5 in Consumer Staples

We are July's #2 ranked stock picker in Healthcare, #5 in Industrials and #5 in Consumer Staples.

by Kyle Guske II

July 8, 20190Comments

Barron’s Features our Research on Safe Dividend Yields

Barron’s featured our recent research on safe dividend yields and KeyCorp (KEY).

by Kyle Guske II

June 7, 20190Comments

June 2019 Stock Picking Accolades: #2 in Healthcare, #6 in Industrials and #10 in Consumer Staples

We are June's #2 ranked stock picker in Healthcare, #6 in Industrials and #10 in Consumer Staples.

by Kyle Guske II

May 6, 20190Comments

Winner of SumZero’s “Think Big” Contest

SumZero selected our January 2019 report on Netflix as a winner of the “Think Big” contest.

by Kyle Guske II

May 6, 20190Comments

May 2019 Stock Picking Accolades: #1 in Healthcare, #5 in Industrials and #5 in Consumer Staples

We are May's #1 ranked stock picker in Healthcare, #5 in Industrials and #5 in Consumer Staples.

by Kyle Guske II

May 2, 20190Comments

Barron’s Features our Recent Netflix Research

Barron’s featured our recent research on Netflix (NFLX).

by Kyle Guske II

April 8, 20190Comments

April 2019 Stock Picking Accolades: #1 in Healthcare, #4 in Industrials and #5 in Consumer Staples

We are April’s #1 ranked stock picker in Healthcare, #4 in Industrials and #5 in Consumer Staples.

by Kyle Guske II

March 20, 20190Comments

Barron’s Features our Recent IPO Research

Barron’s featured our recent IPO coverage on Levi Strauss & Co (LEVI).

by Kyle Guske II

March 7, 20190Comments

March 2019 Stock Picking Accolades: #1 in Healthcare, #3 in Industrials and #5 in Consumer Staples

We are March’s #1 ranked stock picker in Healthcare, #3 in Industrials and #5 in Consumer Staples.

by Kyle Guske II

February 8, 20190Comments

February 2019 Stock Picking Accolades: #1 in Healthcare, #4 in Industrials and #7 in Consumer Staples

New Constructs is February’s #1 ranked stock picker in Healthcare, #4 in Industrials and #7 in Consumer Staples.

by Kyle Guske II

January 8, 20190Comments

#1 Stock Picker – Healthcare LTM – January 2019

New Constructs is January’s #1 ranked stock picker in Healthcare over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

December 11, 20180Comments

Barron’s Features our Recent Long Idea

On Tuesday, Barron’s featured our recent Long Idea - Keep on Trucking with This Undervalued Stock.

by Kyle Guske II

November 28, 20180Comments

#1 Stock Picker – Healthcare LTM – November 2018

New Constructs is November’s #1 ranked stock picker in Healthcare over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

September 7, 20180Comments

#1 Stock Picker – Healthcare LTM – September 2018

New Constructs is September’s #1 ranked stock picker in Healthcare over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

August 2, 20180Comments

#1 Stock Picker – Healthcare Last Twelve Months – August 2018

New Constructs is August’s #1 ranked stock picker in Healthcare over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

February 26, 20180Comments

“Tax Cuts and Confidence Drive Surge of Payouts” – Barron’s

On Saturday, Barron’s featured three stocks on our Safest Dividend Yields Model Portfolio.

by Kyle Guske II

February 5, 20180Comments

“Elon Musk’s New Pay Deal Sets the Wrong Targets” – Barron’s

On Saturday, Barron’s featured our research on a recent Danger Zone and the company’s questionable executive compensation plan.

by Kyle Guske II

February 5, 20180Comments

“Barron’s 100 Most Sustainable Companies: CLX” – Barron’s

On Saturday, Barron’s featured our research on a recent long idea and the company’s strong corporate governance.

by Kyle Guske II

September 28, 20170Comments

“Clean Up With 40 Years of Dividend Boosts” – Barron’s

On Thursday, Barron’s featured our research on a recent long idea.

by Kyle Guske II

July 17, 20170Comments

“Overvalued Tech: Verint” – Barron’s

On Saturday, Barron's featured our research on Verint (VRNT) and the company's misleading use of non-GAAP metrics.

by Kyle Guske II

« Older Articles